UK small-cap RNS · 22 Apr 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies

14:01

Boku, Inc BOKU £382m
Holding(s) in Company Holding
12:00

PureTech Health PRTC £268m
PRTC's Gallop: Positive Ph1 Topline MDS & AML Data
PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)

Project milestones outlook positive −1.4% on the day

Moved: Final LYT-200 overall survival data in H1 2026: on_track → changed – Study completed, but median overall survival in both cohorts is called not fully mature, so final survival data is not yet delivered. · LYT-200 AML development: Phase 1b topline reported; Phase 2 planned → Phase 1b complete; MDS prioritised, AML to follow
08:00

Bodycote BOY £1,541m
Holding(s) in Company Holding
07:09

Neo Energy Metals NEO £15m
Directorate Change Board change
Executive Chair Jason Brewer steps down on 22 April 2026 with the rest of the old board. Neal Froneman, ex-Sibanye CEO, becomes independent Chair, putting a Beisa-experienced team in charge. Wholesale board turnover is a governance reset.

Project milestones outlook positive +27.5% on the day

Moved: Beisa Mine acquisition: One condition precedent outstanding → One condition outstanding; new board in place · Beisa Mine restart: Phase 1 planned to start March 2026 → Implementation Assessment under way · Henkries mining right application: Studies and drilling; application planned → Mining right application pending
07:00

Pulsar Helium Inc PLSR £144m
Secures District-Scale Helium Exploration Option
("Pulsar Michigan"), has entered into an exclusive Option to Lease Non-Hydrocarbon Gas Agreement (the "Option" or "Agreement") with Keweenaw Land Association, Ltd.

Project milestones −4.7% on the day

Moved: new: Falcon Project Michigan exploration option – Option signed; exploration programme to start
07:00

Creo Medical Group CREO £50m
Positive Q1 trading update Trading update
Q1 revenue growth of c.60% hit the top of management's expectations, and the 40-60% full-year growth view is reaffirmed, not raised. Guidance is confirmed, so 'in_line' fits better than 'upgrade'.

Balance-sheet stress / refinancing ahead of expectationsoutlook positivefirst in 7 months +3.9% on the day

Moved: Manufacturing disposal and outsourcing: Agreed, conditional, expected to close in May → Agreed on 16 April; cost saving restated · Path to self-sustaining cashflows: Further cost cut agreed; still loss-making → Revenue growing; cost cuts under way
07:00

Helical HLCL £212m
Trading Update Trading update
Tech-sector letting at The Bower (the weak spot at the half year) is now converting, with 96.6% occupancy possible once leases complete. Paddington is financed and four schemes are under construction, with 100 New Bridge Street close to completing its sale.

Project milestones £166.5m · 78% of mcapoutlook positivefirst in 6 months +0.1% on the day

Moved: 100 New Bridge Street forward sale: Under construction, sale on track → Practical completion expected this month · London office development programme: Three schemes under construction for 2026 → Four schemes under construction · Paddington office scheme: Preparatory works; lender credit approval obtained → Acquired, financed, construction contract signed
07:00

Liontrust Asset Management LIO £171m
Trading Statement Trading update
Net outflows narrowed to £0.8bn from £1.3bn and £500m+ of institutional mandates are due to fund, but AuMA fell to £19.6bn on markets and UK retail outflows of £838m continue.

Upgrade / downgrade cycle £500.0m · 292% of mcapoutlook positive +3.0% on the day

Moved: Net outflows and return to inflows: Acquisition adds AuMA and inflows; core outflows persist → Outflows narrowing; retail outflows persist · River Global Holdings acquisition: Conditional SPA signed; awaiting approvals → River Global shareholders approved; completion pending
07:00

Kenmare Resources (CDI) KMR £200m
Q1 2026 Production Report
Guidance on all metrics is confirmed after the 2025 warnings and shipments match the run rate. But Q1 output fell sharply, and the guide relies on stock drawdown and a Q2 recovery.

Legal & regulatory in lineoutlook mixed −0.4% on the day

Moved: Moma Implementation Agreement extension: Ongoing engagement with Government; near-term resolution sought → Missed 20 March target; talks continue · WCP A upgrade and Nataka transition: Construction complete; commissioning challenges remain → Construction complete; debottlenecking progressing · Value over volume, inventory drawdown: Drawdown under way in Q1 2026 → 99,900 tonnes drawn down in Q1
07:00

GB Group GBG £354m
Trading Statement Trading update
Results are in line with market expectations and the second-half acceleration to mid-single-digit growth promised in November was delivered. Nothing is raised, so this is confirmation rather than an upgrade.

Turnaround plan with targets in lineoutlook positive −1.1% on the day

Moved: Americas Identity to return to growth in H2 FY26: on_track → delivered – Americas Identity returned to growth in the fourth quarter, within H2 FY26 as promised. · Deliver FY26 revenue outlook in line with market expectations: on_track → delivered – FY26 trading performance confirmed in line with market expectations. · Gradually accelerate growth in the near term: pending → delivered – Growth accelerated to mid-single-digits in the second half.